Director at Delek US Holdings (DK) sells 5,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Delek US Holdings director William J. Finnerty sold 5,000 shares of Common Stock in an open-market transaction at $45.50 per share. After the sale, he directly holds 41,369 shares. The transaction was executed under a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FINNERTY WILLIAM J

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S(1)		5,000	D	$45.5	41,369	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Delek US Holdings (DK) report for William J. Finnerty?

Delek US Holdings reported that director William J. Finnerty sold 5,000 shares of Common Stock. The sale was an open-market transaction at $45.50 per share and was carried out under a pre-established Rule 10b5-1 trading plan.

How many Delek US Holdings (DK) shares does William J. Finnerty hold after this Form 4 sale?

After the reported sale, William J. Finnerty directly holds 41,369 shares of Delek US Holdings Common Stock. This figure reflects his share ownership immediately following the 5,000-share open-market transaction disclosed in the Form 4 filing.

At what price were the Delek US Holdings (DK) shares sold in the latest insider transaction?

The 5,000 Delek US Holdings shares were sold at $45.50 per share in an open-market transaction. This price represents the per-share consideration disclosed in the Form 4 for director William J. Finnerty’s reported sale.

Was the Delek US Holdings (DK) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing notes the transaction was made pursuant to a Rule 10b5-1 trading plan. It states the plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for pre-arranged insider trading programs.

Who is the insider involved in the Delek US Holdings (DK) Form 4 transaction?

The insider is William J. Finnerty, a director of Delek US Holdings. He reported an open-market sale of 5,000 shares of Common Stock and now directly owns 41,369 shares, as shown in the Form 4 filing.

What type of security was involved in the Delek US Holdings (DK) insider sale?

The transaction involved Delek US Holdings Common Stock. Director William J. Finnerty sold 5,000 shares of this Common Stock at $45.50 per share in an open-market transaction disclosed in the Form 4.